Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United Kingdom
/
Pharmaceuticals & Biotech
Create a narrative
Haleon Community
LSE:HLN Community
3
Narratives
written by author
0
Comments
on narratives written by author
40
Fair Values set
on narratives written by author
Create a narrative
Haleon
Latest
Undervalued
Overvalued
Community Investing Ideas
Haleon
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Sensodyne IND 20 And Cost Savings Will Strengthen Future Market Position
Key Takeaways Haleon is driving growth through innovation and international expansion in emerging markets, enhancing market share and revenue. Strategic divestments and efficiency programs aim to boost profitability, operational efficiency, and shareholder value.
View narrative
UK£4.04
FV
4.7% undervalued
intrinsic discount
3.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
24
users have followed this narrative
6 days ago
author updated this narrative
Haleon
AN
AnalystHighTarget
Consensus Narrative from 17 Analysts
Aging Global Demand And Digital Reach Will Drive Consumer Healthcare
Key Takeaways Global expansion, innovation, and strong brand positioning are expected to drive multiyear revenue growth and margin improvement beyond current market expectations. Operational efficiencies, digital strategies, and China integration are likely to enhance profitability, free cash flow, and competitive advantage over the long term.
View narrative
UK£5.02
FV
23.3% undervalued
intrinsic discount
4.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
6 days ago
author updated this narrative
Haleon
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Rising Regulatory Costs And Shifting Consumer Preferences Will Undermine Performance
Key Takeaways Rising regulatory costs and evolving health guidelines threaten margins, while core product reformulation may constrain long-term earnings and growth. Shifting consumer preferences and weak innovation expose Haleon to declining demand, competitive pressures, and limited ability to defend its leading brands.
View narrative
UK£3.22
FV
19.7% overvalued
intrinsic discount
2.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
HLN
HLN
Haleon
Your Fair Value
UK£
Current Price
UK£3.85
10.3% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
13b
2015
2018
2021
2024
2025
2027
2030
Revenue UK£13.5b
Earnings UK£1.7b
Advanced
Set Fair Value